OR4M2-OT1: A Potential Drug Target or Biomarker for various Diseases

OR4M2-OT1: A Potential Drug Target or Biomarker for various Diseases

OR4M2-OT1, also known as OR4M2 overlap transcript 1, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. OR4M2-OT1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been associated with the development and progression of various diseases.

The OR4M2 gene family is composed of four genes, OR4M2-OT1, OR4M2-OT2, OR4M2-OT3, and OR4M2-OT4. OR4M2-OT1 is the first gene in the family to be studied and has been shown to be involved in the regulation of gene expression in various organisms. OR4M2-OT1 has been shown to play a role in the regulation of cell adhesion, cell survival, and the response to stimuli, among other things.

Recent studies have suggested that OR4M2-OT1 may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. For example, studies have shown that OR4M2-OT1 is overexpressed in various cancer types, including breast, ovarian, and colorectal cancers. This suggests that targeting OR4M2-OT1 may be a promising strategy for the development of new cancer therapies.

In addition to its potential as a cancer drug target, OR4M2-OT1 has also been suggested as a potential biomarker for neurodegenerative diseases. Studies have shown that OR4M2-OT1 is downregulated in the brains of individuals with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that targeting OR4M2-OT1 may be a promising strategy for the development of new neurodegenerative disease therapies.

OR4M2-OT1 has also been suggested as a potential biomarker for psychiatric disorders. Studies have shown that OR4M2-OT1 is involved in the regulation of gene expression in the brain and that it is implicated in the development and progression of psychiatric disorders. This suggests that targeting OR4M2-OT1 may be a promising strategy for the development of new psychiatric therapies.

In conclusion, OR4M2-OT1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been associated with the development and progression of various diseases. The potential drug target or biomarker status of OR4M2-OT1 makes it an attractive target for further research and may lead to the development of new therapies for cancer, neurodegenerative diseases, and psychiatric disorders.

Protein Name: OR4M2 Overlapping Transcript 1

More Common Targets

OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1